And it's especially true that Cipro is a household name in the U.S. Bayer has also spent hundreds of millions buying research from biotechs like Millennium (nasdaq: MLNM - news - people), Curagen (nasdaq: CRGN - news - people), and Lion Bioscience (nasdaq: LEON - news - people).
The matter became urgent last month following Bayer's withdrawal of an anti-cholesterol drug, marketed under the name Lipobay in Germany and Baycol almost everywhere else.